CN103766887A - Preparation comprising astragalus mongholicus extract - Google Patents
Preparation comprising astragalus mongholicus extract Download PDFInfo
- Publication number
- CN103766887A CN103766887A CN201210414392.7A CN201210414392A CN103766887A CN 103766887 A CN103766887 A CN 103766887A CN 201210414392 A CN201210414392 A CN 201210414392A CN 103766887 A CN103766887 A CN 103766887A
- Authority
- CN
- China
- Prior art keywords
- preparation
- extract
- astragalus mongholicus
- astragalus
- poria cocos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 20
- 235000006533 astragalus Nutrition 0.000 title claims abstract description 9
- 241000045403 Astragalus propinquus Species 0.000 title abstract description 5
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 11
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 10
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 10
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims abstract description 8
- 229940037907 ferrous lactate Drugs 0.000 claims abstract description 8
- 235000013925 ferrous lactate Nutrition 0.000 claims abstract description 8
- 239000004225 ferrous lactate Substances 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 8
- 229940107666 astragalus root Drugs 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 10
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 7
- 241001061264 Astragalus Species 0.000 claims description 5
- 210000004233 talus Anatomy 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 claims 2
- 244000194101 Ginkgo biloba Species 0.000 claims 2
- 244000248825 Peltandra virginica Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 239000004480 active ingredient Substances 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000009636 Huang Qi Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 241000282461 Canis lupus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 240000008670 Pinus densiflora Species 0.000 description 1
- 235000000405 Pinus densiflora Nutrition 0.000 description 1
- 235000011609 Pinus massoniana Nutrition 0.000 description 1
- 241000018650 Pinus massoniana Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000000496 anti-anoxic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation comprising an astragalus mongholicus extract. The preparation comprises the following active ingredients by weight percentage: 15-28% of astragalus mongholicus extract, 30-40% of poria cocos extract, 30-45% of wolfberry extract, 2-10% of ferrous lactate and the balance of auxiliary material. According to the preparation, the traditional Chinese medicinal materials such as the astragalus mongholicus, poria cocos and wolfberry are combined with ferrous lactate scientifically, and the preparation has an obvious effect of improving fatigue resistance and no obvious side effect.
Description
Technical field
The present invention relates to health food technology field, what be specifically related to is a kind of preparation that contains Astragalus Root P.E for alleviating physical fatigue.
Background technology
Modern medicine thinks that fatigue is that body transfinites and the function that causes reduces and occur that the state of body discomfort, main manifestations are tired sleepy, can occur degradation simultaneous phenomenon under dizziness, forgetful, sleep quality.The factor relations such as tired generation and energy substance consumption, metabolite accumulation, homeostasis sexual maladjustment, free radical impact are close.Along with the reinforcement of people's health care consciousness, various anti-fatigue products arise at the historic moment, wherein Chinese medicine series products natural with it, safely, the advantage such as have no side effect, day by day receive people's concern, as aweto capsule, American Ginseng sheet etc.Therefore, exploitation has the health food of the alleviating physical fatigue of tcm characteristic, not only can make up the deficiency of modern medicine in treatment, the advantage of performance traditional Chinese medicine, and also its suitable crowd's scope is wide, and the market demand is large, has wide market prospects.
Summary of the invention
Object of the present invention is just to provide a kind of preparation that contains Astragalus Root P.E for alleviating physical fatigue.Not only dialectical prescription, the fundamentally root of relieving fatigue, also combines nutrient, hardening agent homenergic material, to promote antisecosis.
In order to realize the object of the invention, active component and the weight content thereof of composition said preparation are: Astragalus Root P.E 15-28%, tuckahoe extracts 30-40%, wolfberry fruit extract 30-45%, ferrous lactate 2-10%, remaining is auxiliary material.
In the present invention, Astragalus Root P.E is no less than 20% containing astragalus polyose; Tuckahoe extracts is no less than 30% containing pachymaran; Wolfberry fruit extract is no less than 10% containing LBP-X.
Compared with prior art, advantage of the present invention is; Dialectical prescription in conjunction with nutrient, curative effect is clear and definite.
The Radix Astragali: be the root of legume astragalus mongolicus Astragalus memeranaceus (Fisch.) Bge.var.mongholicus (Bge.) Hsiao or Astragalus membranacus A.membranaceus (Fisch.) Bge..Main product in the Inner Mongol, the ground such as Shanxi, Heilungkiang.Two seasons of spring and autumn excavate, and remove fibrous root and root head, dry, section, raw with or honey process use.The Radix Astragali can promote the renewal of organism metabolism, antifatigue, promotion serum and hepatic protein; There is obvious diuresis, can eliminate Jishengshenqiwan urine albumen; Can improve anaemia animal phenomenon; The hypoglycemia that can raise, reduces hyperglycaemia; Can excitedly breathe; Can strengthen and regulate body's immunity, interferon system is had to facilitation, can improve the premunition of body; The multiple viral institute such as infected by influenza cytopathogenic effect has slight inhibitory action, and influenza virus infected has protective effect; There is antibacterial action more widely; The Radix Astragali, in cell is cultivated, can make cell number showed increased, and Growth of Cells is vigorous, life; Can strengthen myocardial contractive power, protection cardiovascular system, anti-arrhythmia cordis, coronary artery dilator and peripheral vascular, reduce blood pressure, and can reduce platelet adhesion reaction power, reduces thrombosis; Also have reducing blood lipid, anti-ageing, anti-anoxic, radioresistance, the effect such as protect the liver.
Poria cocos: be the dry sclerotia of On Polyporaceae Poria cocos Poria cocos (Schw.) Wolf.Parasitize on the tree roots such as pinaceae plant Japanese red pine or masson pine.Wild or cultivation, main product in Yunnan, the ground such as Anhui, Hubei, Henan, Sichuan.Produce Yunnan person and claim " Yun Ling ", matter is more excellent.More than excavating for 7~September.After digging out, remove silt, bank up after " sweating ", spread out and dry in the air to dry tack free, then " sweating ", after extremely now wrinkle, the large portion of internal moisture scatter and disappear for several times repeatedly, dry in the shade, be called " Poria cocos ".After the infiltration of getting, slightly steam, section, dries in time; Or fresh Poria cocos is pressed to different parts cutting, and dry in the shade, raw using.Poria cocos decoction, syrup, alcohol extract, ether extract, have respectively diuresis, calmness, antitumor, hypoglycemic, the effect that increases myocardial contractive power.Pachymaran has the effect that strengthens immunologic function.Poria cocos has liver protection effect, can reduce gastric secretion, gastric ulcer is had to inhibitory action.
Matrimony vine: be the ripening fruits of plant of Solanaceae lycium barbarum Lycium barbarum L..Main product in Ningxia, the ground such as Gansu, Xinjiang.Two autumn of autumn in summer gathers when fruit is orange red, dry in the air to rhicnosis, then shine to crust stiff, pulp softness, raw using.The fruit of Chinese wolfberry has facilitation to immunity, has immunoregulation effect simultaneously; Can improve plasma testosterone level, play strong effect; Hematopoiesis function is had to facilitation; Normal healthy people is also had to remarkable effect in increasing leukocyte; Anti-ageing, anti-sudden change in addition, antitumor, reducing blood lipid, protect the liver and AFL, hypoglycemic, hypotensive activity.
Ferrous lactate: this product is ferro element replenishers.Iron is the chief component composition of hemoglobin and myoglobins.Hemoglobin is the person that mainly takes oxygen in red blood cell, and myoglobins is the position that muscle cell is stored oxygen, and the needs of oxygen are provided during for muscular movement.With tricarboxylic circulate relevant most of enzymes and the equal iron content of the factor, or only in the time that existing, iron just plays a role.Body lacks iron, can cause and be short of physical strength etc.
The specific embodiment
The preparation of embodiment 1 capsule of the present invention
Astragalus Root P.E 25%, tuckahoe extracts 40%, wolfberry fruit extract 30%, ferrous lactate 5%, remaining is auxiliary material.
The preparation of embodiment 2 tablets of the present invention
Astragalus Root P.E 28%, tuckahoe extracts 30%, wolfberry fruit extract 40%, ferrous lactate 2%.Raw material is added to right amount of auxiliary materials, compressing tablet.
The preparation of embodiment 3 capsules of the present invention
Astragalus Root P.E 15%, tuckahoe extracts 30%, wolfberry fruit extract 45%, ferrous lactate 10%, remaining is auxiliary material.
Claims (2)
1. the preparation that contains ginkgo biloba p.e for alleviating physical fatigue, active component and the weight content thereof of composition said preparation are: Astragalus Root P.E 15-28%, tuckahoe extracts 30-40%, wolfberry fruit extract 30-45%, ferrous lactate 2-10%, remaining is auxiliary material.
2. a kind of preparation that contains ginkgo biloba p.e as claimed in claim 1, is characterized in that, Astragalus Root P.E is no less than 20% containing astragalus polyose; Tuckahoe extracts is no less than 30% containing pachymaran; Wolfberry fruit extract is no less than 10% containing LBP-X.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210414392.7A CN103766887A (en) | 2012-10-26 | 2012-10-26 | Preparation comprising astragalus mongholicus extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210414392.7A CN103766887A (en) | 2012-10-26 | 2012-10-26 | Preparation comprising astragalus mongholicus extract |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103766887A true CN103766887A (en) | 2014-05-07 |
Family
ID=50560012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210414392.7A Pending CN103766887A (en) | 2012-10-26 | 2012-10-26 | Preparation comprising astragalus mongholicus extract |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103766887A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758308A (en) * | 2014-12-10 | 2015-07-08 | 北京康华远景科技股份有限公司 | Traditional Chinese medicine oral liquid capable of improving immunity of livestock and poultry and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634524A (en) * | 2004-10-31 | 2005-07-06 | 青海石油管理局 | Health-care food for improving nutritional anemia |
JP2009179625A (en) * | 2008-01-04 | 2009-08-13 | Kracie Seiyaku Kk | Composition or preparation for internal use having anti-stress/fatigue-preventive effect and skin texture-ameliorating or wrinkle-ameliorating/preventive effect |
CN101703623A (en) * | 2009-11-12 | 2010-05-12 | 西安斯强实业有限公司 | Capsule with effect of relieving physical fatigue |
CN102370170A (en) * | 2011-08-18 | 2012-03-14 | 高益槐 | Health-care food for relieving physical fatigue and preparation method thereof |
-
2012
- 2012-10-26 CN CN201210414392.7A patent/CN103766887A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634524A (en) * | 2004-10-31 | 2005-07-06 | 青海石油管理局 | Health-care food for improving nutritional anemia |
JP2009179625A (en) * | 2008-01-04 | 2009-08-13 | Kracie Seiyaku Kk | Composition or preparation for internal use having anti-stress/fatigue-preventive effect and skin texture-ameliorating or wrinkle-ameliorating/preventive effect |
CN101703623A (en) * | 2009-11-12 | 2010-05-12 | 西安斯强实业有限公司 | Capsule with effect of relieving physical fatigue |
CN102370170A (en) * | 2011-08-18 | 2012-03-14 | 高益槐 | Health-care food for relieving physical fatigue and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758308A (en) * | 2014-12-10 | 2015-07-08 | 北京康华远景科技股份有限公司 | Traditional Chinese medicine oral liquid capable of improving immunity of livestock and poultry and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101703623A (en) | Capsule with effect of relieving physical fatigue | |
CN101972353A (en) | Medicine composition for preventing and treating heart cerebrovascular diseases | |
CN103766885A (en) | Health food for alleviating physical fatigue | |
CN103550399B (en) | Health-care food for relieving physical fatigue, and preparation method thereof | |
CN104738626B (en) | A kind of Halth-care composition, its preparation method and application with strengthen immunity effect | |
CN116173176A (en) | Anti-fatigue traditional Chinese medicine composition and preparation method thereof | |
CN103766888A (en) | Preparation containing American ginseng extract | |
CN103766887A (en) | Preparation comprising astragalus mongholicus extract | |
CN103766881A (en) | Traditional Chinese medicine health product | |
CN103800407A (en) | Health-care product composition | |
CN103800548A (en) | Compound traditional chinese medicine | |
CN103798772A (en) | Health-care product composition | |
CN101991037B (en) | Angelica-aronia melanocarpa pill and manufacturing method thereof | |
CN108079275A (en) | A kind of health Chinese medicine composition for treating hypertension and preparation method thereof | |
CN104905369B (en) | Purple liquid drink of minister in ancient times dragon and preparation method thereof | |
CN103798754A (en) | Traditional chinese medicine composition | |
CN103798756A (en) | Traditional Chinese medicine health food | |
CN103571700A (en) | Cordyceps militaris health wine | |
CN103798758A (en) | Preparation containing ginkgo leaf extract | |
CN103798759A (en) | Preparation containing wolfberry extract | |
CN103798771A (en) | Traditional Chinese medicine extract-containing compound preparation | |
CN101642528A (en) | Production process of compound soft ginsengs | |
CN103766884A (en) | Novel composite preparation agent | |
CN103766886A (en) | Astragalus preparation | |
CN103768246A (en) | Traditional Chinese medicine preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C05 | Deemed withdrawal (patent law before 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140507 |